Steven M. Paul, Director at Sage Therapeutics, Inc. (SAGE), sold 15,758 shares at $161.04 ($2.5M) on 2019-03-21, disclosed to the SEC on 2019-03-22.
Open-market sale of $2.5M SAGE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $161.02 | 1,967 | $317K | 12.5% |
| 2 | $161.02 | 1,967 | $317K | 12.5% |
| 3 | $161.04 | 2,993 | $482K | 19.0% |
| 4 | $161.04 | 2,993 | $482K | 19.0% |
| 5 | $161.05 | 2,919 | $470K | 18.5% |
| 6 | $161.05 | 2,919 |
| $470K |
| 18.5% |
| Total | $161.04 avg | 15,758 | $2.5M | 100% |
| Filing → |
| KRTX | BUY | 2021-08-18 | $501K | — | Filing → |
| ALNY | SELL | 2020-12-22 | $2.1M | — | Filing → |
| KRTX | SELL | 2020-06-30 | $60.5M | — | Filing → |